STAT1 and acute lymphoblastic leukemia: Upon stimulation with IFNg, STAT1 activation resulted in PD-L1 upregulation and in reduction of NK-cell activity against tumor cells in multiple myeloma, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) [57].